首页> 外文OA文献 >Efficacy, Safety, and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury: A Systematic Review
【2h】

Efficacy, Safety, and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury: A Systematic Review

机译:抗凝血栓剂预防急性脊髓损伤患者静脉血栓栓塞的疗效,安全性和时机:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Study Design: Systematic review. Objectives: The objective of this study was to answer 5 key questions: What is the comparative effectiveness and safety of (1a) anticoagulant thromboprophylaxis compared to no prophylaxis, placebo, or another anticoagulant strategy for preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) after acute spinal cord injury (SCI)? (1b) Mechanical prophylaxis strategies alone or in combination with other strategies for preventing DVT and PE after acute SCI? (1c) Prophylactic inferior vena cava filter insertion alone or in combination with other strategies for preventing DVT and PE after acute SCI? (2) What is the optimal timing to initiate and/or discontinue anticoagulant, mechanical, and/or prophylactic inferior vena cava filter following acute SCI? (3) What is the cost-effectiveness of these treatment options? Methods: A systematic literature search was conducted to identify studies published through February 28, 2015. We sought randomized controlled trials evaluating efficacy and safety of antithrombotic strategies. Strength of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Results: Nine studies satisfied inclusion criteria. We found a trend toward lower risk of DVT in patients treated with enoxaparin. There were no significant differences in rates of DVT, PE, bleeding, and mortality between patients treated with different types of low-molecular-weight heparin or between low-molecular-weight heparin and unfractionated heparin. Combined anticoagulant and mechanical prophylaxis initiated within 72 hours of SCI resulted in lower risk of DVT than treatment commenced after 72 hours of injury. Conclusion: Prophylactic treatments can be used to lower the risk of venous thromboembolic events in patients with acute SCI, without significant increase in risk of bleeding and mortality and should be initiated within 72 hours. © 2017, © The Author(s) 2017.
机译:研究设计:系统评价。目的:本研究的目的是回答5个关键问题:(1a)抗凝血栓预防与无预防,安慰剂或另一种预防深静脉血栓形成(DVT)和肺栓塞的抗凝策略相比的相对有效性和安全性是什么( PE)在急性脊髓损伤(SCI)之后? (1b)单独使用机械预防策略或与其他策略组合以预防急性SCI后的DVT和PE? (1c)单独或结合其他预防急性SCI后预防DVT和PE的预防性下腔静脉滤器插入? (2)急性SCI后启动和/或停用抗凝,机械和/或预防性下腔静脉滤器的最佳时机是什么? (3)这些治疗方案的成本效益如何?方法:进行系统的文献检索,以鉴定截至2015年2月28日发表的研究。我们寻求评估抗血栓形成策略的有效性和安全性的随机对照试验。使用建议评估,发展和评估分级(GRADE)系统评估证据的强度。结果:九项研究满足纳入标准。我们发现依诺肝素治疗的患者发生DVT的风险降低。在使用不同类型的低分子量肝素治疗的患者之间或在低分子量肝素和普通肝素之间,患者的DVT,PE,出血和死亡率无显着差异。在SCI的72小时内开始联合使用抗凝剂和机械预防措施,导致DVT的危险性低于受伤72小时后开始的治疗。结论:预防性治疗可用于降低急性SCI患者静脉血栓栓塞事件的风险,而不会显着增加出血和死亡的风险,应在72小时内开始。 ©2017,©作者2017。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号